Introduction

Editorial Board

Co-Editors-in-Chief

• Nitin Joshi, Adis International Limited, Auckland, New Zealand

• Anton van Rensburg, Adis International Limited, Auckland, New Zealand

Editors Emeriti

• Richard Day, St Vincent’s Clinical Campus, UNSW, Sydney, Australia

• William H. Frishman, New York Medical College, Valhalla, NY, USA

• David J. Greenblatt, Tufts University School of Medicine, Boston, MA, USA

• Hannelore Kreckel, University Hospital Gießen-Marburg, Gießen, Germany

• Howard I. Maibach, University of California San Francisco School of Medicine, San Francisco, CA, USA

Aims & Scope

• Review Articles: Comprehensive reviews on clinical use of drugs, disease management, adverse drug reactions, and drug interactions, providing the latest guidelines and treatment decision support.
• Original Research Articles: Studies related to clinical practice and real-world outcomes, including clinical trials, patient-reported outcomes, retrospective analyses, systematic reviews, and meta-analyses.
• Therapy-in-Practice Articles: Expert commentary and opinions on treatment approaches for specific diseases or therapeutic issues from an international perspective.
• Digital Features: Multimedia content such as video abstracts, animations, infographics, podcasts, and teaching materials designed to enhance visibility and educational value.
• Plain Language Summaries: Summaries in simplified language to help non-expert readers understand key medical advances.
• Letters to the Editor: Comments or discussions on published articles for editorial consideration.